BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 35282121)

  • 1. The methylation modification of m6A regulators contributes to the prognosis of ovarian cancer.
    Zhu W; Zhao L; Kong B; Liu Y; Zou X; Han T; Shi Y
    Ann Transl Med; 2022 Jan; 10(2):59. PubMed ID: 35282121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
    Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
    Jiao J; Jiang L; Luo Y
    Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
    Miao C; Fang X; Chen Y; Zhao Y; Guo Q
    Medicine (Baltimore); 2021 Dec; 100(49):e27689. PubMed ID: 34889221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
    Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
    Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and Prognostic Characteristics of m
    Zhang B; Gu Y; Jiang G
    Front Genet; 2020; 11():604597. PubMed ID: 33362863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a Risk Signature Based on m6A RNA Methylation Regulators That Predicts Poor Prognosis in Renal Cell Carcinoma.
    Wei J; Qian Y; Tang Y; Ge X; Jiang K; Fang Y; Fu D; Kong X; Xiao Q; Ding K
    Onco Targets Ther; 2021; 14():413-426. PubMed ID: 33488096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Expression Profile and Prognostic Value of m6A RNA Methylation Regulators in Hepatocellular Carcinoma.
    Chang X; Lv YF; He J; Cao Y; Li CQ; Guo QN
    J Hepatocell Carcinoma; 2021; 8():85-101. PubMed ID: 33738268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer.
    Li Q; Ren CC; Chen YN; Yang L; Zhang F; Wang BJ; Zhu YH; Li FY; Yang J; Zhang ZA
    Front Cell Dev Biol; 2021; 9():703969. PubMed ID: 34631700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
    Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
    Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The methylation modification of m6A regulators contributes to the prognosis of head and neck squamous cell carcinoma.
    Chen Y; Jiang X; Li X; Yan D; Liu J; Yang J; Yan S
    Ann Transl Med; 2021 Aug; 9(16):1346. PubMed ID: 34532483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
    Xu LC; Pan JX; Pan HD
    Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis.
    Wu T; Qian TY; Lin RJ; Jin DD; Xu XB; Huang MX; Ji J; Jiang F; Pan LL; Luo L; Ji YF; Chen QL; Xiao MB
    J Gastrointest Oncol; 2022 Oct; 13(5):2553-2564. PubMed ID: 36388690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.
    Pu Y; Lu X; Yang X; Yang Y; Wang D; Li M; Guan W; Xu M
    J Gastrointest Oncol; 2022 Feb; 13(1):1-12. PubMed ID: 35284129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.